Edesa Biotech, Inc.
EDSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540159
No open-market purchases or sales by Edesa Biotech, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $30.0M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Edesa Biotech, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +3 vs. Q2 2025
- Shares held
- 2.88M
- +768.6K (+36.5%) vs. Q2 2025
- Total value
- $7.10M
- +$2.82M (+66.0%) vs. Q2 2025
- New holders
- 5
- 4 more added
- Sold out
- 2
- 3 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $30.0M |
| Q1 2026 | 28 | $13.8M |
| Q4 2025 | 22 | $4.34M |
| Q3 2025 | 23 | $7.10M |
| Q2 2025 | 20 | $4.28M |
| Q1 2025 | 20 | $6.89M |
| Q4 2024 | 17 | $350.1K |
| Q3 2024 | 18 | $718.2K |
| Q2 2024 | 17 | $645.1K |
| Q1 2024 | 17 | $450.9K |
| Q4 2023 | 19 | $507.1K |
| Q3 2023 | 20 | $1.26M |
| Q2 2023 | 22 | $1.63M |
| Q1 2023 | 26 | $2.05M |
| Q4 2022 | 22 | $3.53M |
| Q3 2022 | 21 | $494.2K |
| Q2 2022 | 24 | $2.26M |
| Q1 2022 | 23 | $5.51M |
| Q4 2021 | 26 | $2.03M |
| Q3 2021 | 23 | $2.85M |
| Q2 2021 | 18 | $1.37M |
| Q1 2021 | 16 | $773.7K |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Edesa Biotech, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 687,500 | $1.70M | 0.02% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 687,500 | $1.70M | 1.60% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 687,500 | $1.70M | 1.38% | +687,500 | New |
| Nantahala Capital Management, LLC | 625,000 | $1.54M | 0.10% | 00.0% | Unchanged |
| Vanguard Group Inc | 45,543 | $111.1K | 0.00% | +29,679+187.1% | Added |
| Geode Capital Management, LLC | 45,234 | $110.4K | 0.00% | +17,278+61.8% | Added |
| Commonwealth Equity Services, LLC | 37,548 | $93.0K | 0.00% | +2,545+7.3% | Added |
| Renaissance Technologies LLC | 25,000 | $61.8K | 0.00% | +25,000 | New |
| Susquehanna International Group, LLP | 14,610 | $35.6K | 0.00% | +14,610 | New |
| Citadel Advisors LLC | 14,032 | $34.2K | 0.00% | −9,482−40.3% | Reduced |
| Citigroup Inc | 2,000 | $4.88K | 0.00% | +2,000 | New |
| UBS Group AG | 1,819 | $4.49K | 0.00% | +1,136+166.3% | Added |
| Royal Bank of Canada | 1,816 | $4.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,279 | $3.16K | 0.00% | −1,064−45.4% | Reduced |
| TD Waterhouse Canada Inc. | 142 | $362 | 0.00% | 00.0% | Unchanged |
| Fifth Third Bancorp | 100 | $247 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 51 | $126 | 0.00% | −3−5.6% | Reduced |
| Global Retirement Partners, LLC | 25 | $62 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 6 | $14 | 0.00% | +6 | New |
| Danske Bank A/S | 1 | $2 | 0.00% | 00.0% | Unchanged |
| AllSquare Wealth Management LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| LRI Investments, LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Dogwood Wealth Management LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 0 | $0 | 0.00% | −584−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −29−100.0% | Sold out |